Research institutions should create oversight committees to guide human embryonic stem-cell studies according to common guidelines, a panel of experts said on Tuesday in Washington, D.C....
If we assume that the biotech industry started in the late 1970s with the first IPOs taking place in 1980 (Amgen and Cetus), then biotech is already an industry more than 25 years old....
Madison, Wis. — Scientists at the University of Wisconsin-Madison have sucessfully injected stem cells into rats' spines in a way that could lead to treatments for degenerative diseases – but they did not use the controversial embryonic stem cells....
Some biochips barely cover a human thumbnail, but they can hold over a half of a million samples of DNA. The emerging technology has also found its place in protein research, the next step in studying disease....
Major biotech stocks have dropped after the discovery of unexpected drug side effects. Has the FDA been too lax?...
Milwaukee — Sensient Technologies Corp. (NYSE:SXT) reported $12.8 million in profits on $251.9 million in revenues for its first quarter ended March 31....
Pedrus Pharma, a University of Wisconsin-Madison spinoff that has sped to the finals in the Governor's Business Plan Contest, may put a stop to the annual flu vaccine hoopla, among other things....
The Wisconsin Assembly voted late Tuesday night to amend a bill granting tax credits so that any corporation doing research on newly created human embryonic stem cells would be denied....
The leaders of California's $3 billion bond initiative to fund stem-cell research, under pressure from advocacy groups, have voted in new rules against conflicts of interest....
Milwaukee — As William D. Gregory, dean of the University of Wisconsin-Milwaukee's school of engineering, leaves his post behind, he has more to look forward to than fewer budget headaches....